同步放化疗治疗局限期小细胞肺癌时每日一次或两次的胸部放疗
Once- or twice-daily thoracic radiation in limited-stage small-cell lung cancer treated with concurrent chemoradiotherapy.
作者信息
Harada Ken, Inoki Kazuya, Ichimura Takenori, Taruno Kanae, Shinjo Hidenori, Yamaji Noyuri, Noma Hisashi, Ota Erika, Hasegawa Takeshi
机构信息
Department of Radiation Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Division of Gastroenterology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.
出版信息
Cochrane Database Syst Rev. 2025 Sep 25;9(9):CD016084. doi: 10.1002/14651858.CD016084.
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of once-daily radiotherapy versus twice-daily radiotherapy concurrently with chemotherapy for optimal survival outcomes in people with limited-stage small-cell lung cancer (LS-SCLC).
摘要
这是一项Cochrane系统评价（干预措施）的方案。目标如下：评估对于局限期小细胞肺癌（LS-SCLC）患者，每日一次放疗与每日两次放疗联合化疗相比，在实现最佳生存结局方面的获益与危害。
相似文献
1
Once- or twice-daily thoracic radiation in limited-stage small-cell lung cancer treated with concurrent chemoradiotherapy.同步放化疗治疗局限期小细胞肺癌时每日一次或两次的胸部放疗
Cochrane Database Syst Rev. 2025 Sep 25;9(9):CD016084. doi: 10.1002/14651858.CD016084.
2
Surgery for limited-stage small-cell lung cancer.局限期小细胞肺癌的手术治疗
Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD011917. doi: 10.1002/14651858.CD011917.pub2.
3
A simplified scoring system for predicting treatment response in limited-stage small-cell lung cancer (EAST score).一种用于预测局限期小细胞肺癌治疗反应的简化评分系统（EAST评分）。
Future Oncol. 2025 Feb;21(4):473-481. doi: 10.1080/14796694.2024.2444858. Epub 2024 Dec 29.
4
Platinum and etoposide chemotherapy, durvalumab with thoracic radiotherapy in the first-line treatment of patients with extensive-stage small-cell lung cancer: CHEST-RT (TROG 20.01) Trial - protocol for a phase II study.铂类和依托泊苷化疗联合度伐利尤单抗同步胸部放疗用于广泛期小细胞肺癌患者的一线治疗：CHEST-RT（TROG 20.01）试验——一项II期研究方案
BMJ Open. 2025 Jul 7;15(7):e101571. doi: 10.1136/bmjopen-2025-101571.
5
Immunotherapy concurrently administered with chemoradiotherapy in limited-stage small-cell lung cancer.免疫疗法与放化疗同时用于局限期小细胞肺癌的治疗。
BMC Cancer. 2025 Jul 1;25(1):1077. doi: 10.1186/s12885-025-14480-7.
6
No survival benefit with early incorporation of thoracic radiotherapy using daily fractionation in patients with limited-stage small cell lung cancer undergoing chemoradiotherapy in the modern era: A systematic review and meta-analysis.在现代时代，接受化放疗的局限期小细胞肺癌患者中，每日分割胸部放疗的早期纳入并未带来生存获益：一项系统评价和荟萃分析。
Radiother Oncol. 2023 Jul;184:109696. doi: 10.1016/j.radonc.2023.109696. Epub 2023 May 6.
7
Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538.局限期小细胞肺癌的预后因素：CALGB 30610-RTOG 0538 的二次分析。
JAMA Netw Open. 2024 Oct 1;7(10):e2440673. doi: 10.1001/jamanetworkopen.2024.40673.
8
Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status.CONVERT试验方案——同步每日一次与每日两次放疗：一项针对局限期小细胞肺癌（LS-SCLC）且体能状态良好患者的同步放化疗国际双臂随机对照试验，比较每日两次与每日一次放疗方案
BMJ Open. 2016 Jan 20;6(1):e009849. doi: 10.1136/bmjopen-2015-009849.
9
[A Phase I/II Study of Chemotherapy Concurrent with Twice-daily Radiotherapy
Schedules by Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-stage Small Cell Lung Cancer].一项关于强度调制放射治疗采用同步整合加量技术、每日两次放疗方案联合化疗治疗局限期小细胞肺癌的I/II期研究
Zhongguo Fei Ai Za Zhi. 2017 Jan 20;20(1):28-34. doi: 10.3779/j.issn.1009-3419.2017.01.04.
10
Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.放疗生物有效剂量增加与局限期小细胞肺癌患者生存期延长相关：一项系统评价
PLoS One. 2016 May 26;11(5):e0156494. doi: 10.1371/journal.pone.0156494. eCollection 2016.
本文引用的文献
1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据：全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.局限期小细胞肺癌高剂量每日一次胸部放疗：CALGB 30610（Alliance）/RTOG 0538。
J Clin Oncol. 2023 May 1;41(13):2394-2402. doi: 10.1200/JCO.22.01359. Epub 2023 Jan 9.
3
Radiotherapy Fraction in Limited-Stage Small Cell Lung Cancer in the Modern Era: A Systematic Review and Meta-Analysis of 8006 Reconstructed Individual Patient Data.现代局限期小细胞肺癌的放疗分割：对8006例重建个体患者数据的系统评价和荟萃分析
Cancers (Basel). 2022 Dec 31;15(1):277. doi: 10.3390/cancers15010277.
4
Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists.局限期小细胞肺癌治疗策略的实践模式：中国肿瘤学家调查
Front Oncol. 2022 May 12;12:872324. doi: 10.3389/fonc.2022.872324. eCollection 2022.
5
Hypofractionated standard radiotherapy for locally advanced limited-stage small cell lung cancer.局部晚期局限期小细胞肺癌的大分割标准放疗
J Thorac Dis. 2022 Feb;14(2):306-320. doi: 10.21037/jtd-21-1566.
6
Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.每日一次（OD）与每日两次（BID）放化疗治疗局限期小细胞肺癌（LS-SCLC）：一项随机临床试验的荟萃分析。
Radiother Oncol. 2022 Aug;173:41-48. doi: 10.1016/j.radonc.2022.01.032. Epub 2022 Jan 29.
7
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明：系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
8
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer.ESTRO ACROP 指南：小细胞肺癌胸部放射治疗中靶区定义。
Radiother Oncol. 2020 Nov;152:89-95. doi: 10.1016/j.radonc.2020.07.012. Epub 2020 Jul 13.
9
Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline.《小细胞肺癌放射治疗：ASTRO 临床实践指南》。
Pract Radiat Oncol. 2020 May-Jun;10(3):158-173. doi: 10.1016/j.prro.2020.02.009. Epub 2020 Mar 23.
10
A Meta-Analysis of the Efficacy and Toxicity of Twice-Daily vs. Once-Daily Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer Based on Randomized Controlled Trials.基于随机对照试验的每日两次与每日一次同步放化疗治疗局限期小细胞肺癌疗效和毒性的Meta分析
Front Oncol. 2020 Jan 8;9:1460. doi: 10.3389/fonc.2019.01460. eCollection 2019.
Zotero 插件